1. Home
  2. KYMR vs RRC Comparison

KYMR vs RRC Comparison

Compare KYMR & RRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$137.32

Market Cap

9.0B

Sector

Health Care

ML Signal

N/A

Logo Range Resources Corporation

RRC

Range Resources Corporation

N/A

Current Price

$51.20

Market Cap

9.8B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
KYMR
RRC
Founded
2015
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.8B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
KYMR
RRC
Price
$137.32
$51.20
Analyst Decision
Strong Buy
Hold
Analyst Count
24
20
Target Price
★ $145.22
$52.26
AVG Volume (30 Days)
916.3K
★ 5.5M
Earning Date
10-29-2026
10-27-2026
Dividend Yield
N/A
★ 0.78%
EPS Growth
N/A
★ 151.38
EPS
N/A
★ 3.02
Revenue
$39,211,000.00
★ $3,115,515,000.00
Revenue This Year
$153.48
$20.08
Revenue Next Year
N/A
$3.15
P/E Ratio
★ N/A
$16.97
Revenue Growth
N/A
★ 28.90
52 Week Low
$61.50
$32.68
52 Week High
$142.92
$56.99

Technical Indicators

Market Signals
Indicator
KYMR
RRC
Relative Strength Index (RSI) 68.28 60.05
Support Level $104.96 $36.65
Resistance Level N/A $56.99
Average True Range (ATR) 7.62 2.28
MACD 2.10 -0.44
Stochastic Oscillator 83.72 61.85

Price Performance

Historical Comparison
KYMR
RRC

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

About RRC Range Resources Corporation

Range Resources is an exploration and production firm whose operations represent a pure play in the Marcellus shale, located in the Appalachian region of Southwest Pennsylvania. The company went public as Lomak Petroleum in 1980 and later reorganized as Range Resources in 1998. After an expensive 10-year venture with a multi-basin strategy, Range Resources found its identity as an Appalachian natural gas producer, offloading its Permian assets in 2013. Range quickly became a leading US gas producer after its merger with Memorial Resource Development in 2016. Following the merger, Range saw its operational unit costs rise to an uncompetitive level and subsequently sold the assets in 2020 to return to its roots as an Appalachian producer.

Share on Social Networks: